Figure 8From: NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphomaCo-treatment with small-molecule inhibitors of NF-κB, STAT3 and/or PI3K additively inhibits the proliferation of iMycEμ-1 cells. MTS/PMS cell proliferation assay after 24-hour treatment with low doses of LY, LC and WHI in isolation or in various combinations, as indicated. Box at the bottom gives the average percent (%) growth inhibition. Data were normalized to DMSO-treatment controls, and error bars represent the standard deviation from a representative experiment performed in triplicate.Back to article page